Veru, Inc. (VERU) Prices 6.45M Share Common Offering at $15.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
After-Hours Stock Movers 02/17: (SNBR) (TLRY) (WK) Higher; (IMBI) (STMP) (SPWR) Lower (more...)
February 17, 2021 5:54 PM ESTAfter-Hours Stock Movers
iMedia Brands, Inc. (NASDAQ: IMBI) 16.4% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
Sleep Number Corporation (NASDAQ: SNBR) 12.6% HIGHER; reported Q4 EPS of $2.19, $0.75 better than the analyst estimate of $1.44. Revenue for the quarter came in at $568 million versus the consensus estimate of $551.5 million. Sleep Number Corporation sees FY2021 EPS of at least $6.00, versus the consensus of $4.48.
Tilray, Inc. (NASDAQ:... More
Veru (VERU) Announces Proposed Public Offering of Common Stock
February 17, 2021 4:01 PM ESTVeru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced today that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Veru intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. The offering is subject to... More

